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Background/aim: To investigate the influence of thiopental (85 mg/kg, intraperitoneally (ip)), and ketamine+xylazine (ketamine 75
mg/kg and xylazine 8 mg/kg, ip) anesthesia on the incidence and duration of ischemia/reperfusion-induced arrhythmias.
Materials and methods: Myocardial ischemia was induced by a 6-min ligation of the left anterior descending coronary artery, followed
by a 6-min reperfusion. Measurements were taken of the incidence and duration of ventricular arrhythmias, the mean arterial blood
pressure and heart rate, and the pressure rate-product (as an index of myocardial oxygen consumption).
Results: The arrhythmia score and the incidence of ventricular fibrillation and tachycardia were significantly decreased in the
ketamine+xylazine-anesthetized rats compared with the thiopental-anesthetized group (arrhythmia score: 2.0 ± 2.1 versus 3.7 ± 1.2, P
< 0.05). The heart rate was significantly lower in the ketamine+xylazine group during the entire experiment, whilst the pressure-rate
product was also significantly lower in the ketamine+xylazine group at different time points of the ischemia and reperfusion periods.
Conclusion: Ketamine+xylazine anesthesia has a strong antiarrhythmic effect and an apparent depressive action on the heart rate
and the myocardial oxygen consumption index. Therefore, ketamine+xylazine anesthesia is not appropriate for the evaluation of
possible antiarrhythmic agents. Thiopental anesthesia is preferable to ketamine+xylazine anesthesia in the in vivo ischemia-reperfusion
arrhythmia model.
Key words: Anesthetics, ischemia/reperfusion, ventricular arrhythmias, rat

1. Introduction
Occlusion of the coronary arteries induces myocardial
ischemia. Although thrombolytic and angioplastic therapy
restore the blood flow through blocked arteries to save
the myocardium from eventual necrosis in a hospitalized
patient, the reperfusion can lead to the occurrence of
life-threatening arrhythmias (1). Thus, the reperfusioninduced arrhythmias after transient episodes of ischemia
represent a clinical problem that limits the benefits of
thrombolytic and angioplastic therapy (2).
For decades, researchers have sought to clarify the
cellular mechanisms underlying the occurrence of
ventricular arrhythmias and to test the antiarrhythmic
potential of drugs and substances using the in vivo
ischemia-reperfusion arrhythmia model (3–5). The main
issue is an appropriate choice of the anesthetic agent used
in this model (6). The use of different types of anesthesia
may be the reason for certain discrepancies between the
results of ischemia/reperfusion (I/R)-induced arrhythmia
studies in the literature. The anesthetic agents used in this
* Correspondence: ersozgonca67@hotmail.com

model were reported to influence the occurrence of I/Rinduced arrhythmias (7–10).
Ketamine hydrochloride is a dissociative anesthetic
that has certain undesirable effects, such as muscle
hypertonicity, myoclonus, and violent recovery (11,12).
Therefore, ketamine is commonly used in combination with
an alpha-2 agonist to counteract these undesirable effects
(13). Xylazine hydrochloride is a typical alpha-2 agonist of
the nonopioid group with analgesic, sedative, and muscle
relaxant effects (14). Thiopental, a thiobarbiturate, is also
an anesthetic substance with certain side effects, such as
respiratory depression (15).
Both thiopental and ketamine+xylazine (K+X) have
been used in studies involving experimental cardiology
(16–24). However, there are only a few studies addressing
the influence of anesthetics on I/R-induced arrhythmias
(7–10), whilst there has been no comparison between
these two commonly used anesthetics (thiopental and
K+X) in an in vivo I/R arrhythmia model. With this in
mind, the aim of the present study was to compare the
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duration and severity of ventricular arrhythmias induced
by coronary artery occlusion and reperfusion, as well as
the hemodynamic parameters between thiopental- and
K+X-anesthetized rats.
2. Materials and methods
2.1. Animals
Twenty-six male Wistar albino rats (6–7 month olds
weighing 340 ± 30 g) were used in the present study. They
were provided by the Faculty of Medicine, Bülent Ecevit
University, Zonguldak. The animals were kept in a room at
a temperature of 21 ± 2 °C, with 40%–65% humidity and
a 12-h light/dark cycle. The animals consumed tap water
and standard rat pellet food ad libitum. The experimental
procedures the animals underwent were in accordance
with the guidelines and recommendations of the World
Medical Association. All of the experimental procedures
in this study were discussed and approved by the Animal
Research Local Ethical Committee of Bülent Ecevit
University, Zonguldak (protocol no: 2010-16-27/05).
2.2. Anesthetic agents
Thiopental sodium (Abbott, İstanbul, Turkey), at a dose
of 85 mg/mL/kg was administrated intraperitoneally (ip).
Ketamine, at a dose of 75 mg/kg (Alfamine 10%, Alfasan
Int., Woerden, Netherlands), and xylazine at a dose of 8
mg/kg (Alfazyne 2%, Alfasan Int., Woerden, Netherlands),
were administrated ip in a volume of 1 mL/kg. Satisfactory
anesthesia was defined by lack of reflexes in response to
pinch stimuli in the tail and foot, as well as the presence
of deep respiration. When necessary, 10% of the initial
anesthetic dose was applied ip to reach the anesthetic stage.
2.3.
Surgical
procedures
and
hemodynamic
measurements
The ischemia and reperfusion protocols performed in our
study were previously defined by Bozdoğan et al. (24).
Briefly, the rats were anaesthetized via an injection of
thiopental sodium ip (85 mg/kg) and placed on an animal
rectal temperature controller (RTC 9404-A, Commat Ltd,
Ankara, Turkey) to maintain their body temperature in
the range of 37 ± 1 °C during the experimental period.
The trachea and the left carotid artery were cannulated
for artificial respiration and the measurement of arterial
blood pressure, respectively (blood pressure transducer,
SS 13 L, Biopac Systems, Goleta, CA, USA). A standard
limb lead II electrocardiogram (ECG) and arterial blood
pressure were recorded and monitored throughout the
experimental period (data acquisition system MP35,
Biopac Systems) (Figure 1). Thoracotomy was performed
by cutting the fourth and fifth ribs on the left side of the
chest.The animal respirator was started immediately, using
room air to provide artificial ventilation (60 strokes/min,
at a tidal volume of 1.5 mL/100 g; SAR 830, IITC Life
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Science, Woodland Hills, CA, USA). The pericardium was
incised and then the hearts were gently exteriorized. A 5/0
silk suture was passed around the left anterior descending
coronary artery (LAD) approximately 2–3 mm from its
origin. The heart was then replaced and allowed to stabilize
for 10 min. During this period, rats with a sustained
decrease in mean arterial blood pressure (MABP) values
below 70 mmHg or ventricular arrhythmias prior to the
ligation were excluded. After heart rate (HR) and blood
pressure stabilization, the slip loop was made using
the loose ends of the previously placed silk suture. The
coronary artery occlusion was induced by ligation of the
LAD with the slip loop. The slip loop was then loosened
by pulling the loose end of the loop to permit reperfusion.
The heart was removed and cannulated through the
aorta following the termination of the reperfusion period.
In order to wash out the coronary vessels, the heart was
subjected to retrograde perfusion with 10 mL of saline
solution at 37 °C. The heart was then perfused with 2 mL
of 96% ethanol to specify the zone at risk, followed by
reocclusion of the left coronary artery. The nonischemic
zone of the heart was thoroughly perfused with ethanol
and appeared white. The zones that were not perfused with
ethanol were defined as the zone at risk and remained red
(original tissue color). Finally, the total ventricle and zone
at risk were weighed; the zone at risk was measured as the
percentage of total ventricle weight (25).
Various results were seen in all rats for which a
successful coronary artery occlusion had been performed.
This included ST segment elevation and increased QRS
amplitude on ECG, a 20%–40% reduction in arterial blood
pressure compared to the preischemic values, and zone at
risk values greater than 40%. Reversal of ischemia-induced
ST segment changes and recovery of MABP were observed
in all rats that had undergone successful reperfusion.
A total of 6 animals were omitted on the basis of these
criteria.
2.4. Recording and arrhythmia analysis
By using a data acquisition system, ECG and blood
pressure recordings were analyzed to determine the HR
and MABP, and systolic and diastolic blood pressure
(SABP, DABP) parameters at regular intervals throughout
the ischemia and reperfusion periods (MP 35, Biopac
Systems). The pressure-rate product (PRP) is the product
of mean blood pressure and heart rate (PRP = SABP ×
HR/1000), which corresponds to the oxygen and energy
demand of the myocardium. PRP was calculated as an
index of myocardial oxygen consumption according to
Baller et al. (26).
In accordance with the Lambeth Conventions
(27), arrhythmias were identified during the ischemia
and reperfusion periods as ventricular fibrillation
(VF), ventricular tachycardia (VT), and other types of
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Figure 1. Original electrocardiogram tracings (recorded at speed 80 mm/s) and arterial blood
pressure recordings: (A) Sinus rhythm just before the coronary ligation; (B) ST-segment elevation
and the increase in QRS amplitude; (C) Other types of arrhythmias (VPC) including bigeminy,
single extrasystole, and salvo; (D) ventricular tachycardia (VT); (E) ventricular fibrillation (VF).

arrhythmias (ventricular premature contraction (VPC))
including bigeminy, salvos and single extrasystoles (Figure
1). A grade was given to each animal as an index of the
severity of arrhythmias (arrhythmia score), according to
the following scale: 0- no arrhythmia; 1- in the absence of
VF, the duration of VT and/or VPC is shorter than 10 s or
equal to 10 s; 2- in the absence of VF, the duration of VT
and/or VPC is between 11 and 30 s; 3- in the absence of VF,
the duration of VT and/or VPC is between 31 and 90 s; 4-

the duration of reversible VF is shorter than 10 s or equal
to 10 s and/or the duration of VT and/or VPC is between
91 and 180 s; 5- the duration of VF is longer than 10 s and/
or the duration of VT and/or VPC is longer than 180 s; and
6- irreversible VF (28). For both groups measurements
were taken of the durations of arrhythmic attacks and
arrhythmic periods, which are the time intervals between
the onset and the end of the arrhythmias, the incidence of
arrhythmia types and mortality and the arrhythmia scores.
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A HR below 200 beats/min was defined as bradycardia,
and the incidence of bradycardia was determined for both
ischemia and reperfusion periods.
2.5. Statistical analysis
The GraphPad statistical software package was used for
statistical analysis (GraphPad Prism 5, San Diego, CA,
USA). Fisher’s exact test was used for the statistical analysis
of the survival rate and the incidence of arrhythmias. The
other parameters were analyzed using Student’s two-tailed
t test. Preocclusion and postocclusion MABP/HR values
were also compared using Student’s two-tailed t test. If the
data did not follow normal distribution, the nonparameter
Mann–Whitney U test was applied. Data were expressed
as mean ± standard deviation (SD).
3. Results
3.1. Hemodynamic parameters
Characteristically, MABP fell immediately following the
ligation in both groups upon occlusion of the LAD (P
< 0.001). Following reperfusion, the MABP recovered
and approached the preischemic values in thiopentalanesthetized rats. Because the MABP did not recover in the
K+X-anesthetized rats during the late phase of reperfusion,
the MABP of this group was significantly lower compared
with that of the thiopental-anesthetized rats at 3 and 5 min
of reperfusion (P < 0.05) (Figure 2). The DABP values of
the K+X-anesthetized rats were also significantly lower
than those of the thiopental-anesthetized group at the
same time points (P < 0.05) (data not shown).

The HR values of the K+X-anesthetized rats were
significantly lower than those of the thiopentalanesthetized group before coronary artery occlusion and
during the entire occlusion and reperfusion period (P <
0.0001) (Figure 3).
In the K+X-anesthetized group, PRP values were
lower than in the thiopental-anesthetized group. These
differences reached significance during the ligation period
(P < 0.05) and at 3 and 5 min of the reperfusion period (P
< 0.0001) (Table 1).
3.2. Arrhythmias during ischemia and reperfusion
The myocardial zone at risk was equal between the
two groups (Table 2). The ligation of the LAD resulted
in the generation of arrhythmias, occurring as VPC.
However, the incidence and the duration of VPC were
not significantly different between the groups. Indeed,
neither group experienced any VF or VT. Bradycardia was
only observed in 3 animals anesthetized with K+X during
ischemia. However, the incidence of bradycardia was not
different between the two groups (data not shown).
The reperfusion-induced arrhythmias were more
severe than the arrhythmias that developed during the 6
min of ischemia, as expected, and appeared within 10–30
s immediately following the reperfusion. In the K+Xanesthetized group, the incidence of VF and VT during
reperfusion was significantly lower than in the thiopentalanesthetized animals (P < 0.05 and P < 0.0001, respectively),
whilst the incidence of bradycardia was nonsignificantly
higher than in the thiopental-anesthetized animals (P =
0.867) (Table 3).
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Figure 2. Mean arterial blood pressure (mmHg) values plotted
against time in anesthetized rats with thiopental (85 mg/kg, ip,
broken lines) and ketamine-xylazine (75 mg/kg and 8 mg/kg,
respectively, ip, solid lines) during ischemia and reperfusion
periods. Arrows indicate coronary artery occlusion and
reperfusion. Values represent means ± standard deviation. *P <
0.05: significantly different from thiopental. n = 9–9.
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Figure 3. Heart rate (beats/min) values plotted against time in
anesthetized rats with thiopental (85 mg/kg, ip, broken lines) and
ketamine-xylazine (75 mg/kg and 8 mg/kg, respectively, ip, solid
lines) during ischemia and reperfusion periods. Arrows indicate
coronary artery occlusion and reperfusion. Values represent
means ± standard deviation. *P < 0.0001: significantly different
from thiopental. n = 9–9.
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Table 1. The effects of thiopental and ketamine+xylazine anesthesia on pressure rate product (mmHg min–1 × 1000).
0
(Basal)

1
(Lig 1 min)

3
(Lig 3 min)

5
(Lig 5 min)

7
(Rep 1 min)

9
(Rep 3 min)

Mean ± SD

39 ± 11

31 ± 12

29 ± 12

29 ± 13

25 ± 15

34 ± 10

95% Confidence interval

(30.94–47.86)

(21.11–40.23)

(20.23–38.14)

(19.51–39.23)

(50.02–75.98)

(70.97–94.03)

(74.82–105.2)

Mean ± SD

39 ± 11

17 ± 4*

15 ± 3*

15 ± 5

16 ± 6**

17 ± 6**

95% Confidence interval

(30.94–47.86)

(14.07–21.07)

(12.4–18.21)

(13.46–17.44)

(56.76–74.11)

(51.37–79.63)

(54.83–83.84)

0.025

0.008

0.032

0.0002

0.0002

Groups

11
(Rep 5 min)

Thiopental (n = 9)
35 ± 9

Ketamine+xylazine (n = 9)

P value

15 ± 4*

n: The number of animals that survived after 6 min of reperfusion.
Lig: Ligation, Rep: Reperfusion. *P < 0.05, **P < 0.0001: Compared with thiopental group.

Table 2. The effects of thiopental and ketamine+xylazine anesthesia on the duration of arrhythmias during 6 min of reperfusion.

Zone at risk
(% of total)

Arrhythmic
period (s)

Arrhythmia
score

Length of arrhythmias (s)
VF

VT

VPC

Total

Mean ± SD

49 ± 7

207 ± 46

3.7 ± 1.2

8 ± 19

47 ± 44

20 ± 6

75 ± 20

95% Confidence interval

(43.39–53.01)

(102.5313.3)

(2.81–4.56)

(6.76–22.77)

(13.1 –80.17)

(6.83–32.72)

(27.69–121.4)

Mean ± SD

49 ± 5

54 ± 22**

2.0 ± 2.1*

2 ± 6*

5 ± 14**

10 ± 4

17 ± 8*

95% Confidence interval

(43.76–54.04)

(2.54–105.5)

(0.49–3.51)

(2.46–6.24)

(5.57–15.79)

(0.19–20.41)

(1.49–36.16)

0.004

0.042

0.044

0.002

Groups
Thiopental (n = 9)

Ketamine+xylazine (n = 9)

P value

0.011

n: The number of animals that survived after 6 min of reperfusion. VF: Ventricular fibrillation; VT: Ventricular tachycardia; VPC: Ventricular premature
contraction; Total: The total length of VF, VT, and VPC. *P < 0.05, **P < 0.001: Compared with thiopental group.

Table 3. The effects of thiopental and ketamine+xylazine anesthesia on the incidence of arrhythmias during 6 min of reperfusion.
Groups

N

Mortality index
N /%

10
10

Incidence of arrhythmias (n*/%)
VF

VT

VPC

Bradycardia

1/10

7/70

10/100

10/100

0/0

1/10

1/10*

2/20**

7/70

4/40

0.012

0.0007

Thiopental
Mean ± SD
Ketamine+xylazine
Mean ± SD
P value

N: The number of animals just before the reperfusion. N: The number of dead animals after 6 min of reperfusion.
n*: The number of animals that experienced arrhythmias.
VF: Ventricular fibrillation; VT: Ventricular tachycardia; VPC: Ventricular premature contraction.
*P < 0.05, **P < 0.0001: Compared with thiopental group.
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In the K+X-anesthetized group, the arrhythmia
score, the duration of VF and VT, the total length of the
arrhythmias, and the length of the arrhythmic period were
all significantly lower than in the thiopental-anesthetized
rats (arrhythmia score: 2.0 ± 2.1 versus 3.7 ± 1.2, P < 0.05)
(Table 2).
4. Discussion
The present results reveal the novel finding that K+Xanesthetized rats undergoing acute coronary occlusion
and reperfusion exhibit a lower incidence of VF and VT,
a shorter duration of VT, and a lower total length of the
arrhythmias than thiopental-anesthetized rats. To date, no
comparable studies have compared the effects of these two
anesthetics on I/R-induced arrhythmias. However, our
finding is similar to the observations reported by Baczko
et al., who compared the effects of ketamine/diazepam
(instead of K+X) with the effects of pentobarbital and
urethane anesthesia on I/R-induced arrhythmias in rats.
These researchers reported that ketamine/diazepam
anesthesia had an antiarrhythmic effect compared with the
other anesthetic substances (9).
A previous in vivo study, which compared the effects
of thiopental anesthesia with the effects of urethane and
pentobarbital, revealed that the duration of ventricular
arrhythmias in thiopental-anesthetized rats was shorter
than in a pentobarbital-treated group (10). Our study
may be regarded as complementary to this study, in the
sense that the effect of K+X anesthesia was also compared
to the effects of thiopental anesthesia on I/R-induced
arrhythmias.
Thiopental has been shown to increase the duration of
I/R-induced arrhythmias in previous isolated heart-model
studies (29,30). These observations correspond with the
results of our experiment, which revealed a significantly
longer duration of ventricular arrhythmias in thiopentalanesthetized rats following reperfusion.
The present study reveals that K+X anesthesia reduces
the HR of rats compared with thiopental anesthesia.
In accordance with this finding, previous studies also
demonstrated a sustained decrease in the HR after K+X
administration in rats (31–33). The nonphysiological
bradycardia caused by K+X anesthesia during the entire
experiment should be reason enough to exclude this
anesthetic from use in such studies. The underlying
mechanism of the effect of K+X anesthesia on the HR may
be explained by the effect of xylazine, which promotes a
decrease in sympathetic activity and an increase in vagal
activity (34). Xylazine action overrides the increased
sympathetic activity and decreases vagal tone induced by
ketamine (12).
In our experiments, the MABP decreased in both groups
following ligation, as expected. Thiopental anesthesia had
a stable influence on the MABP during the experiment,
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as the MABP recovered in thiopental-anesthetized rats
but not in K+X-anesthetized rats following reperfusion.
This result reveals that thiopental anesthesia has a more
normotensive effect during reperfusion. This finding is in
agreement with the results obtained by Wixon et al., who
described a cardiodepressant effect of K+X anesthesia (35).
Indeed, experimental studies have shown that the
HR during acute I/R is an important determinant of
susceptibility to reperfusion arrhythmias (36,37), with
higher rates predisposing the rat hearts to arrhythmias.
In a recent in vivo study, Ng et al. demonstrated that
reducing the HR during ischemia reduces the incidence of
reperfusion arrhythmias and suggested that the HR during
ischemia is a major determinant of reperfusion arrhythmias
(38). In the present study, the lower arrhythmic activity in
K+X-anesthetized rats can be attributed to the anesthesia’s
HR-lowering effect. More specifically, the HR values were
significantly lower than the physiological level during both
ischemia and reperfusion periods in K+X-anesthetized
rats.
The notion that HR reduction during ischemia is
protective against I/R-induced arrhythmias is based on
the hypothesis that lowering the HR causes a reduction
in myocardial oxygen consumption and can attenuate the
severity of ischemia (39,40). In our study, the myocardial
oxygen consumption was also lower in the K+Xanesthetized group when we consider the PRP results.
Therefore, our finding that PRP is decreased in K+Xanesthetized rats supports the suggestion that the lower
arrhythmic activity observed in K+X-anesthetized rats is
dependent on the anesthesia’s HR-lowering effect.
It has been shown that ATP dependent potassium
(KATP) channel blockage confers protection against I/Rinduced arrhythmias (23,24). Ketamine inhibits the KATP
channel activity in a concentration-dependent manner
in the rat heart (41). Therefore, in the present study,
the possible inhibition of the KATP channel by ketamine
may also contribute to the antiarrhythmic effect of K+X
anesthesia.
In conclusion, because K+X anesthesia does not allow
for the development of severe ventricular arrhythmias,
this type of anesthesia is not an appropriate choice for
cardiovascular experiments designed to investigate the
effect of potentially antiarrhythmic drugs. This anesthesia
may be preferable for use in experiments investigating
proarrhythmic agents. Thiopental anesthesia appears
to be a more appropriate choice in the in vivo ischemiareperfusion arrhythmia model. Future studies are
needed to clarify the antiarrhythmic mechanism of
ketamine+xylazine anesthesia.
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